- The Initiative
- What's Residual Risk?
- R3I Videos & Slides
- R3I Events
|Confirm your password|
|I agree to receive the R3i newsletter|
|1972 - 1978 Medical school||Kumamoto University
School of Medicine
|1978-1980 Internship||Kumamoto University School of Medicine 2nd Department of Medicine and Kumamoto Central Hospital|
|1981-1984 Resident||National Cardiovascular Center|
|1981-1984 Fellow||Department of Cardiovascular Medicine Kumamoto University|
|1985-1986 Assistant in Medicine||Health Management Center Kumamoto University|
|1987-1991 Assistant Professor of Medicine||Department of Cardiovascular Medicine, Kumamoto University|
|1991-1997 Lecturer of Medicine||Department of Cardiovascular Medicine, Kumamoto University|
|1997-2000 Associate Professor of Medicine||Department of Cardiovascular Medicine, Kumamoto University|
|2000-2003 Professor of Medicine||Department of Cardiovascular Medicine, Kumamoto University|
|2003- Professor of Medicine||Department of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University|
|2010- Professor of Medicine|| Department of Cardiovascular Medicine,
Graduate School of Medical Sciences
Faculty of Life Sciences Kumamoto University
|2012- Professor of Medicine||Department of Cardiovascular Medicine, Graduate School of Medical Sciences (Department Name changed in Japanese) Faculty of Life Sciences Kumamoto University|
|2011-||Deputy Director General of the Hospital, National Cerebral and
Cardiovascular Center (An additional post)
I hold the posts of Professor of Medicine of Kumamoto University And Deputy Director General of the Hospital, National Cerebral And Cardiovascular Center (Osaka).
|2015-||Deputy Director General of the Hospital, National Cerebral and Cardiovascular Center|
|2016-||President National Cerebral and Cardiovascular Center|
|1980-1981||General Doctor, Amakusa Chuo Hospital|
|1986-1987||Director of Division of Cardiology, Yatsushio General Hospital|
|Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, Jinnouchi H, Sugiyama S, Saito Y, for the Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators. |
Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients with Type 2 Diabetes.
The Journal of the American Medical Association 300(18):2134-2141 2008
|Ogawa H, Kim-Mitsuyama S., Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K, for the OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Group. |
Angiotensin II Receptor Blocker-based Therapy in Japanese Elderly, High-risk, Hypertensive Patients.
The American Journal of Medicine 125(10):981-990 2012
|Kojima S, Matsui K, Hiramitsu S, Hisatome I, Waki M, Uchiyama K, Yokota N, Tokutake E, Wakasa Y, Jinnouchi H, Kakuda H, Hayashi T, Kawai N, Mori H, Sugawara M, Ohya Y, Kimura K, Saito Y, Ogawa H. Febuxostat for Cerebral and Cardiorenovascular Events Prevention Study. |
European Heart Journal 40(22):1778-1786, 2019.
|Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. |
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
The New England Journal of Medicine 381(12):1103-1113, 2019.